CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and Controversies Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Original Research2020 Nov, 76 (19) 2197–2207.

JOURNAL:J Am Coll Cardiol. Article Link

Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization

ME Farkouh , LC Godoy, V Fuster et al. Keywords: diabetes; coronary revascularization; LDL-Cholesterol

Full Text PDF